Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab

Published:2013-03-27 Issue:6 Volume:95 Page:852-858
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Vo Ashley A.,Petrozzino Jeffrey,Yeung Kai,Sinha Aditi,Kahwaji Joseph,Peng Alice,Villicana Rafael,Mackowiak John,Jordan Stanley C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference18 articles.

1. . Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure.;Einecke;Am J Transplant,2009

2. . Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.;Sellares;Am J Transplant,2012

3. . Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure.;Gaston;Transplantation,2010

4. . Rituximab and intravenous immune globulin for desensitization during renal transplantation.;Vo;N Engl J Med,2008

5. . Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.;Vo;Transplantation,2010

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Therapies for Highly Sensitized Patients on the Waiting List;Kidney360;2024-07-12

2. Glycolysis Changes in Alloreactive Memory B Cells in Highly Sensitized Kidney Transplant Recipients Undergonig Desensitization Therapy;Transplant International;2024-07-08

3. Imlifidase in kidney transplantation;Clinical Kidney Journal;2024-02-09

4. Economic and humanistic burden in kidney transplant rejection: a literature review;Expert Review of Pharmacoeconomics & Outcomes Research;2024-01-29

5. The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risks;International Journal of Urology;2024-01-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3